{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T23:53:39Z","timestamp":1790639619155,"version":"4.1.0"},"reference-count":39,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2007,5,1]],"date-time":"2007-05-01T00:00:00Z","timestamp":1177977600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2007,5,1]],"date-time":"2007-05-01T00:00:00Z","timestamp":1177977600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Blood Cells, Molecules, and Diseases"],"published-print":{"date-parts":[[2007,5]]},"DOI":"10.1016\/j.bcmd.2007.01.003","type":"journal-article","created":{"date-parts":[[2007,3,10]],"date-time":"2007-03-10T06:55:51Z","timestamp":1173509751000},"page":"280-286","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":64,"title":["The expression of CXCR4 is down-regulated on the CD34+ cells of patients with myelofibrosis with myeloid metaplasia"],"prefix":"10.1016","volume":"38","author":[{"given":"Vittorio","family":"Rosti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margherita","family":"Massa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro M.","family":"Vannucchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaetano","family":"Bergamaschi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rita","family":"Campanelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Pecci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianluca","family":"Viarengo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina","family":"Meli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monia","family":"Marchetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Guglielmelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward","family":"Bruno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingjiang","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald","family":"Hoffman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Barosi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bcmd.2007.01.003_bib1","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1053\/j.seminhematol.2005.05.018","article-title":"Idiopathic myelofibrosis","volume":"42","author":"Barosi","year":"2005","journal-title":"Semin. Hematol."},{"key":"10.1016\/j.bcmd.2007.01.003_bib2","doi-asserted-by":"crossref","first-page":"3249","DOI":"10.1182\/blood.V98.12.3249","article-title":"Diagnostic and clinical relevance of the number of circulating CD34+ cells in myelofibrosis with myeloid metaplasia","volume":"98","author":"Barosi","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.bcmd.2007.01.003_bib3","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1126\/science.283.5403.845","article-title":"Dependence of human stem cell engraftment and repopulation of NOD\/SCID mice on CXCR4","volume":"283","author":"Peled","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.bcmd.2007.01.003_bib4","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1016\/S0301-472X(02)00883-4","article-title":"Current understanding of stem cell mobilization: the roles of chemokines, proteolytic enzymes, adhesion molecules, cytokines, and stromal cells","volume":"30","author":"Lapidot","year":"2000","journal-title":"Exp. Hematol."},{"key":"10.1016\/j.bcmd.2007.01.003_bib5","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1634\/stemcells.2004-0342","article-title":"Trafficking of normal stem cells and metastasis of cancer stem cells involve similar mechanisms: pivotal role of the SDF-1-CXCR4 axis","volume":"23","author":"Kucia","year":"2005","journal-title":"Stem Cells"},{"key":"10.1016\/j.bcmd.2007.01.003_bib6","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1182\/blood-2003-04-1115","article-title":"Neutrophil-derived MMP-9 mediates synergistic mobilization of hematopoietic stem and progenitor cells by the combination of G-CSF and the chemokines GRObeta\/CXCL2 and GRObetaT\/CXCL2delta4","volume":"103","author":"Pelus","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.bcmd.2007.01.003_bib7","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/S0301-472X(02)00788-9","article-title":"Mobilization by either cyclophosphamide or granulocyte colony-stimulating factor transforms the bone marrow into a highly proteolytic environment","volume":"30","author":"Levesque","year":"2002","journal-title":"Exp. Hematol."},{"key":"10.1016\/j.bcmd.2007.01.003_bib8","doi-asserted-by":"crossref","first-page":"4508","DOI":"10.1182\/blood-2004-08-3238","article-title":"Constitutive mobilization of CD34+ cells into the peripheral blood in idiopathic myelofibrosis may be due to the action of a number of proteases","volume":"105","author":"Xu","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.bcmd.2007.01.003_bib9","doi-asserted-by":"crossref","first-page":"3676","DOI":"10.1182\/blood-2005-09-3826","article-title":"Relation between JAK2 (V617F) mutation status, granulocyte activation, and constitutive mobilization of CD34+ cells into peripheral blood in myeloproliferative disorders","volume":"107","author":"Passamonti","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.bcmd.2007.01.003_bib10","first-page":"3106","article-title":"CXCR4 neutralization, a novel therapeutic approach for non-Hodgkin's lymphoma","volume":"62","author":"Bertolini","year":"2002","journal-title":"Cancer Res."},{"key":"10.1016\/j.bcmd.2007.01.003_bib11","doi-asserted-by":"crossref","first-page":"3772","DOI":"10.1182\/blood-2005-09-3592","article-title":"AMD3100 mobilizes hematopoietic stem cells with long-term repopulating capacity in nonhuman primates","volume":"107","author":"Larochelle","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.bcmd.2007.01.003_bib12","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.exphem.2004.11.008","article-title":"The CXCR4 agonist peptide, CTCE-0021, rapidly mobilizes polymorphonuclear neutrophils and hematopoietic progenitor cells into peripheral blood and synergizes with granulocyte colony-stimulating factor","volume":"33","author":"Pelus","year":"2005","journal-title":"Exp. Hematol."},{"key":"10.1016\/j.bcmd.2007.01.003_bib13","doi-asserted-by":"crossref","first-page":"9448","DOI":"10.1073\/pnas.95.16.9448","article-title":"Impaired B-lymphopoiesis, myelopoiesis, and derailed cerebellar neuron migration in CXCR4- and SDF-1 deficient mice","volume":"95","author":"Ma","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bcmd.2007.01.003_bib14","doi-asserted-by":"crossref","first-page":"2676","DOI":"10.1158\/0008-5472.CAN-04-2152","article-title":"p210BCR-ABL inhibits SDF-1 chemotactic response via alteration of CXCR4 signaling and down-regulation of CXCR4 expression","volume":"65","author":"Geay","year":"2005","journal-title":"Cancer Res."},{"key":"10.1016\/j.bcmd.2007.01.003_bib15","doi-asserted-by":"crossref","unstructured":"H.K. Kim, M.D. Sierra, C.K. Williams, et al., G. G-CSF downregulation of CXCR4 expression identified as a mechanism for mobilization of myeloid cells, Blood prepublished online March 14, 2006.","DOI":"10.1182\/blood-2005-10-4162"},{"key":"10.1016\/j.bcmd.2007.01.003_bib16","first-page":"415","article-title":"A longitudinal study of the JAK2(V617F) mutation in myelofibrosis with myeloid metaplasia: analysis at two time points","volume":"91","author":"Mesa","year":"2006","journal-title":"Haematologica\/THJ"},{"key":"10.1016\/j.bcmd.2007.01.003_bib17","doi-asserted-by":"crossref","first-page":"2098","DOI":"10.1182\/blood-2005-08-3395","article-title":"V617F mutation in JAK2 is associated with poorer survival in idiopathic myelofibrosis","volume":"107","author":"Campbell","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.bcmd.2007.01.003_bib18","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1111\/j.1365-2141.2005.05776.x","article-title":"The JAK2(V617F) tyrosine kinase mutation in myelofibrosis with myeloid metaplasia: lineage specificity and clinical correlates","volume":"131","author":"Tefferi","year":"2005","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.bcmd.2007.01.003_bib19","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1046\/j.1365-2141.1999.01262.x","article-title":"The Italian Consensus Conference on diagnostic criteria for myelofibrosis with myeloid metaplasia","volume":"104","author":"Barosi","year":"1999","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.bcmd.2007.01.003_bib20","series-title":"Chronic Idiopathic Myelofibrosis in World Health Organization of Tumors of Hematopoietic and Lymphoid Tissues","first-page":"35","author":"Thiele","year":"2001"},{"key":"10.1016\/j.bcmd.2007.01.003_bib21","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1182\/blood.V88.3.1013.1013","article-title":"Prognostic factors in agnogenic myeloid metaplasia: a report on 195 cases with a new scoring system","volume":"88","author":"Dupriez","year":"1996","journal-title":"Blood"},{"key":"10.1016\/j.bcmd.2007.01.003_bib22","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1200\/JCO.2004.08.160","article-title":"Low-dose thalidomide ameliorates cytopenias and splenomegaly in myelofibrosis with myeloid metaplasia: a phase II trial","volume":"22","author":"Marchetti","year":"2004","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.bcmd.2007.01.003_bib23","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1002\/(SICI)1097-0320(19980415)34:2<61::AID-CYTO1>3.0.CO;2-F","article-title":"Single platform flow cytometric absolute CD34+ cell counts based on the ISHAGE guidelines. International Society of Hematotherapy and Graft Engineering","volume":"34","author":"Keeney","year":"1998","journal-title":"Cytometry"},{"key":"10.1016\/j.bcmd.2007.01.003_bib24","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1002\/(SICI)1097-0320(19971015)30:5<214::AID-CYTO2>3.0.CO;2-H","article-title":"U.S.\u2013Canadian Consensus recommendations on the immunophenotypic analysis of hematologic neoplasia by flow cytometry: standardization and validation of laboratory procedures","volume":"30","author":"Stelzer","year":"1997","journal-title":"Cytometry"},{"key":"10.1016\/j.bcmd.2007.01.003_bib25","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1182\/blood.V95.3.756","article-title":"Chemokine SDF-1 enhances circulating CD34+ cells proliferation in synergy with cytokines: possible role in progenitor survival","volume":"95","author":"Lataillade","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.bcmd.2007.01.003_bib26","doi-asserted-by":"crossref","first-page":"5688","DOI":"10.1200\/JCO.2005.09.021","article-title":"Circulating CD34+, CD133+, and vascular endothelial growth factor receptor 2-positive endothelial progenitor cells in myelofibrosis with myeloid metaplasia","volume":"23","author":"Massa","year":"2005","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.bcmd.2007.01.003_bib27","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1084\/jem.185.1.111","article-title":"The chemokine SDF-1 is a chemoattractant for human CD34+ hematopoietic progenitor cells and provides a new mechanism to explain the mobilization of CD34+ progenitors to peripheral blood","volume":"185","author":"Aiuti","year":"1997","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.bcmd.2007.01.003_bib28","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1016\/S0301-472X(02)00883-4","article-title":"Current understanding of stem cell mobilization: the roles of chemokines, proteolytic enzymes, adhesion molecules, cytokines, and stromal cells","volume":"30","author":"Lapidot","year":"2002","journal-title":"Exp. Hematol."},{"key":"10.1016\/j.bcmd.2007.01.003_bib29","first-page":"4233","article-title":"The BCR\/ABL oncogene alters the chemotactic response to stromal-derived factor-1alpha","volume":"94","author":"Salgia","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.bcmd.2007.01.003_bib30","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1084\/jem.20020519","article-title":"Crosstalk between BCR\/ABL oncoprotein and CXCR4 signaling through a Src family kinase in human leukemia cells","volume":"196","author":"Ptasznik","year":"2002","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.bcmd.2007.01.003_bib31","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1634\/stemcells.20-3-259","article-title":"Immature leukemic CD34+CXCR4+ cells from CML patients have lower integrin-dependent migration and adhesion in response to the chemokine SDF-1","volume":"20","author":"Peled","year":"2002","journal-title":"Stem Cells"},{"key":"10.1016\/j.bcmd.2007.01.003_bib32","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1038\/sj.leu.2401875","article-title":"Biological effects of stroma-derived factor-1 alpha on normal and CML CD34+ haemopoietic cells","volume":"14","author":"Durig","year":"2000","journal-title":"Leukemia"},{"key":"10.1016\/j.bcmd.2007.01.003_bib33","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1158\/0008-5472.CAN-04-3531","article-title":"Epigenetic up-regulation of C\u2013C chemokine receptor 7 and C\u2013X\u2013C chemokine receptor 4 expression in melanoma cells","volume":"65","author":"Mori","year":"2005","journal-title":"Cancer Res."},{"key":"10.1016\/j.bcmd.2007.01.003_bib34","first-page":"70","article-title":"The chemokine receptor CXCR4 is regulated by DNA methylation in pancreatic cancer","volume":"4","author":"Sato","year":"2005","journal-title":"Biol. Ther."},{"key":"10.1016\/j.bcmd.2007.01.003_bib35","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1080\/10428190500353315","article-title":"Age and hemoglobin level emerge as most important clinical prognostic parameters in patients with osteomyelofibrosis: introduction of a simplified prognostic score","volume":"47","author":"Strasser-Weippl","year":"2006","journal-title":"Leuk. Lymphoma"},{"key":"10.1016\/j.bcmd.2007.01.003_bib36","doi-asserted-by":"crossref","first-page":"2942","DOI":"10.1182\/blood-2003-07-2607","article-title":"Overexpression of CXCR4 on human CD34+ progenitors increases their proliferation, migration, and NOD\/SCID repopulation","volume":"103","author":"Kahn","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.bcmd.2007.01.003_bib37","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1038\/382635a0","article-title":"Defects of B-cell lymphopoiesis and bone-marrow myelopoiesis in mice lacking the CXC chemokine PBSF\/SDF-1","volume":"382","author":"Nagasawa","year":"1996","journal-title":"Nature"},{"key":"10.1016\/j.bcmd.2007.01.003_bib38","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/S1074-7613(00)80046-1","article-title":"The chemokine receptor CXCR4 is required for the retention of B lineage and granulocytic precursors within the bone marrow microenvironment","volume":"10","author":"Ma","year":"1999","journal-title":"Immunity"},{"key":"10.1016\/j.bcmd.2007.01.003_bib39","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1309\/7A5JU9KJK89VQPH9","article-title":"Studies of the site and distribution of CD34+ cells in idiopathic myelofibrosis","volume":"123","author":"Ni","year":"2005","journal-title":"Am. J. Clin. Pathol."}],"container-title":["Blood Cells, Molecules, and Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1079979607000216?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1079979607000216?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T12:23:52Z","timestamp":1761049432000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1079979607000216"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,5]]},"references-count":39,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2007,5]]}},"alternative-id":["S1079979607000216"],"URL":"https:\/\/doi.org\/10.1016\/j.bcmd.2007.01.003","relation":{},"ISSN":["1079-9796"],"issn-type":[{"value":"1079-9796","type":"print"}],"subject":[],"published":{"date-parts":[[2007,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The expression of CXCR4 is down-regulated on the CD34+ cells of patients with myelofibrosis with myeloid metaplasia","name":"articletitle","label":"Article Title"},{"value":"Blood Cells, Molecules, and Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcmd.2007.01.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2007 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}